These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16893489)

  • 1. The Lyme vaccine: a cautionary tale.
    Nigrovic LE; Thompson KM
    Epidemiol Infect; 2007 Jan; 135(1):1-8. PubMed ID: 16893489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Lyme vaccine: a cautionary tale.
    McSweegan E
    Epidemiol Infect; 2007 Jan; 135(1):9-10. PubMed ID: 17064458
    [No Abstract]   [Full Text] [Related]  

  • 3. Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old.
    Beran J; De Clercq N; Dieussaert I; Van Hoecke C
    Clin Infect Dis; 2000 Dec; 31(6):1504-7. PubMed ID: 11096024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lyme disease vaccine--a public health perspective.
    Shen AK; Mead PS; Beard CB
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s247-52. PubMed ID: 21217171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention of Lyme disease with vaccine.
    Poland GA; Jacobson RM
    Vaccine; 2001 Mar; 19(17-19):2303-8. PubMed ID: 11257352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correcting a public health fiasco: The need for a new vaccine against Lyme disease.
    Plotkin SA
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s271-5. PubMed ID: 21217175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines against Lyme disease: What happened and what lessons can we learn?
    Poland GA
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s253-8. PubMed ID: 21217172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyme disease prevention and vaccine prophylaxis.
    Hayney MS; Grunske MM; Boh LE
    Ann Pharmacother; 1999 Jun; 33(6):723-9. PubMed ID: 10410187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress and controversy surrounding vaccines against Lyme disease.
    Hanson MS; Edelman R
    Expert Rev Vaccines; 2003 Oct; 2(5):683-703. PubMed ID: 14711329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response in dogs naturally infected with Borrelia burgdorferi sensu lato and in dogs after immunization with a Borrelia vaccine.
    Leschnik MW; Kirtz G; Khanakah G; Duscher G; Leidinger E; Thalhammer JG; Joachim A; Stanek G
    Clin Vaccine Immunol; 2010 May; 17(5):828-35. PubMed ID: 20219882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic infection with Borrelia burgdorferi.
    Steere AC; Sikand VK; Schoen RT; Nowakowski J
    Clin Infect Dis; 2003 Aug; 37(4):528-32. PubMed ID: 12905137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and development of a novel vaccine for protection against Lyme borreliosis.
    Comstedt P; Hanner M; Schüler W; Meinke A; Lundberg U
    PLoS One; 2014; 9(11):e113294. PubMed ID: 25409015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Lyme disease vaccines: past and future concerns.
    Nardelli DT; Munson EL; Callister SM; Schell RF
    Future Microbiol; 2009 May; 4(4):457-69. PubMed ID: 19416014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to a Lyme disease vaccine.
    Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyme disease: uphill struggle.
    Abbott A
    Nature; 2006 Feb; 439(7076):524-5. PubMed ID: 16452949
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of Lyme disease after tick bites. A cost-effectiveness analysis.
    Magid D; Schwartz B; Craft J; Schwartz JS
    N Engl J Med; 1992 Aug; 327(8):534-41. PubMed ID: 1298217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should speculations about immune-mediated adverse effects of Lyme disease vaccine deter us from giving it?
    Sigal L
    Cleve Clin J Med; 2000 Dec; 67(12):873-4. PubMed ID: 11127980
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.
    Steere AC; Sikand VK; Meurice F; Parenti DL; Fikrig E; Schoen RT; Nowakowski J; Schmid CH; Laukamp S; Buscarino C; Krause DS
    N Engl J Med; 1998 Jul; 339(4):209-15. PubMed ID: 9673298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.